Business Context and Reporting Period
This Form 6-K filing by Embraer S.A. covers the month of November 2025. The report details a new commercial aircraft order received at the Dubai Air Show on November 17, 2025, involving Helvetic Airways, a Swiss carrier.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period. The document focuses exclusively on a specific commercial transaction.
Material Changes and New Orders
- New Order: Helvetic Airways placed a firm order for three Embraer E195-E2 aircraft.
- Purchase Rights: The agreement includes five additional purchase rights, potentially increasing the total order to eight aircraft.
- Configuration: Aircraft will feature a 134-seat single-class layout with modern Recaro seating.
- Delivery Schedule: The first aircraft is scheduled for delivery at the end of 2026.
- Fleet Impact: This order supports Helvetic Airways' plan to grow its E2 fleet from 12 to up to 20 aircraft.
Management Commentary and Outlook
Arjan Meijer, President and CEO of Embraer Commercial Aviation, stated that the order reinforces the E2 family's value in European operations, citing its performance, economics, and environmental credentials. Tobias Pogorevc, CEO of Helvetic Airways, emphasized the aircraft's fuel efficiency, low noise emissions, and suitability for their ACMI (wet-lease) operations. The filing highlights the strategic alignment between Embraer's sustainable aviation goals and Helvetic's fleet modernization strategy.
Investor Verification Checklist
- Verify the total value of the firm order and purchase rights in Embraer's subsequent financial reports.
- Monitor the delivery schedule for the three firm E195-E2 aircraft, with the first expected in late 2026.
- Track Helvetic Airways' exercise of the five purchase rights to determine the final fleet expansion size.
- Review future filings for the impact of this order on Embraer's backlog and revenue recognition timeline.